Investment firms  Jeito Capital raised a record $1.2 billion for Jeito II Fund to support clinical stage biopharma companies developing breakthrough therapies for diseases with high unmet medical needs  Kurma Partners raised €215 million for Biofund IV to support the discovery and development of disruptive therapeutic solutions for severe or incurable diseases  British Business Bank made a £100 million cornerstone commitment to Apposite Healthcare Growth Fund I to support innovative companies across medical products, diagnostics, life science tools, digital health and […]